Brain Proteomics

267

[37] M. Abyadeh, V. Gupta, N. Chitranshi, et al., “Mitochondrial dysfunc-

tion in alzheimer’s disease-a proteomics perspective,” Expert review of

Proteomics, vol. 18, no. 4, pp. 295–304, 2021.

[38] D. A. Butterfield and D. Boyd-Kimball, “Redox proteomics and amyloid

β-peptide: insights into alzheimer disease,” Journal of neurochemistry,

vol. 151, no. 4, pp. 459–487, 2019.

[39] E. Drummond, S. Nayak, A. Faustin, et al., “Proteomic differences in

amyloid plaques in rapidly progressive and sporadic alzheimer’s disease,”

Acta neuropathologica, vol. 133, pp. 933–954, 2017.

[40] C. F. Mendonça, M. Kuras, F. C. S. Nogueira, et al., “Proteomic signa-

tures of brain regions affected by tau pathology in early and late stages

of alzheimer’s disease,” Neurobiology of disease, vol. 130, p. 104509, 2019.

[41] G. Sathe, M. Albert, J. Darrow, et al., “Quantitative proteomic analysis

of the frontal cortex in alzheimer’s disease,” Journal of neurochemistry,

vol. 156, no. 6, pp. 988–1002, 2021.

[42] E. B. Dammer, D. M. Duong, I. Diner, et al., “Neuron enriched nu-

clear proteome isolated from human brain,” Journal of proteome research,

vol. 12, no. 7, pp. 3193–3206, 2013.

[43] E. C. Johnson, E. B. Dammer, D. M. Duong, et al., “Deep proteomic

network analysis of alzheimer’s disease brain reveals alterations in rna

binding proteins and rna splicing associated with disease,” Molecular neu-

rodegeneration, vol. 13, pp. 1–22, 2018.

[44] E. S. Drummond, S. Nayak, B. Ueberheide, et al., “Proteomic anal-

ysis of neurons microdissected from formalin-fixed, paraffin-embedded

alzheimer’s disease brain tissue,” Scientific reports, vol. 5, no. 1, p. 15456,

2015.

[45] E. Drummond, S. Nayak, G. Pires, et al., “Isolation of amyloid plaques

and neurofibrillary tangles from archived alzheimer’s disease tissue using

laser-capture microdissection for downstream proteomics,” Laser Capture

Microdissection: Methods and Protocols, pp. 319–334, 2018.

[46] A. K. Carlisle, J. Götz, and L.-G. Bodea, “Three methods for examining

the de novo proteome of microglia using boncat bioorthogonal labeling

and funcat click chemistry,” STAR protocols, vol. 4, no. 3, p. 102418,

2023.

[47] B. Olsson, R. Lautner, U. Andreasson, et al., “Csf and blood biomarkers

for the diagnosis of alzheimer’s disease: a systematic review and meta-

analysis,” The Lancet Neurology, vol. 15, no. 7, pp. 673–684, 2016.